Edesa Biotech Management

How experienced are the management team and are they aligned to shareholders interests?


Average management tenure


Par Nijhawan (51 yo)





Dr. Pardeep Nijhawan, also known as Par, M.D., FRCPC, AGAF serves as Chief Executive Officer, Company secretary and Director at Edesa Biotech, Inc. since June 7, 2019 and having previously founded and led...

CEO Compensation Analysis

Par Nijhawan's Compensation vs Edesa Biotech Earnings
How has Par Nijhawan's remuneration changed compared to Edesa Biotech's earnings?
DateTotal Comp.SalaryCompany Earnings
Jun 30 2022n/an/a


Mar 31 2022n/an/a


Dec 31 2021n/an/a


Sep 30 2021US$1mUS$315k


Jun 30 2021n/an/a


Mar 31 2021n/an/a


Dec 31 2020n/an/a


Sep 30 2020US$411kUS$300k


Jun 30 2020n/an/a


Mar 31 2020n/an/a


Dec 31 2019n/an/a


Sep 30 2019US$165kUS$105k


Jun 30 2019n/an/a


Mar 31 2019n/an/a


Dec 31 2018US$61kUS$27k


Compensation vs Market: Par's total compensation ($USD1.32M) is above average for companies of similar size in the US market ($USD787.63K).

Compensation vs Earnings: Par's compensation has increased whilst the company is unprofitable.

Leadership Team

Experienced Management: EDSA's management team is considered experienced (3.3 years average tenure).

Board Members

Experienced Board: EDSA's board of directors are considered experienced (3.3 years average tenure).